Novartis Book Value Per Share from 2010 to 2025

NVS Stock

USD 110.14 0.24 0.22%

Novartis Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share will likely drop to 17.82 in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Novartis AG ADR according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

21.93141153

Current Value

17.82

Quarterly Volatility

6.5051783

Credit Downgrade

Yuan Drop

Covid

Check Novartis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novartis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 B, Interest Expense of 571.2 M or Selling General Administrative of 7.3 B, as well as many indicators such as Price To Sales Ratio of 2.76, Dividend Yield of 0.0247 or PTB Ratio of 2.35. Novartis financial statements analysis is a perfect complement when working with Novartis Valuation or Volatility modules.

Check out the analysis of Novartis Correlation against competitors.

Latest Novartis' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Novartis AG ADR over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Novartis' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novartis' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 22.30 X

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Novartis Book Value Per Share Regression Statistics

	Arithmetic Mean	26.39
	Geometric Mean	25.26
	Coefficient Of Variation	24.65
	Mean Deviation	4.85
	Median	28.63
	Standard Deviation	6.51
	Sample Variance	42.32
	Range	25.662
	R-Value	(0.08)
	Mean Square Error	45.02
	R-Squared	0.01
	Significance	0.76
	Slope	(0.11)
	Total Sum of Squares	634.76

Novartis Book Value Per Share History

	2025	17.82
	2024	21.93
	2023	22.37
	2022	27.24
	2021	30.24
	2020	24.89
	2019	24.25

Other Fundumenentals of Novartis AG ADR

Tangible Book Value Per Share

Novartis Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Capital Stock	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.91	0.52	0.66	0.92	0.92	0.74	-0.01	0.86	0.41	0.02	0.47	0.02	0.93	0.7	0.98	-0.1	0.84	0.14	0.37	0.3	-0.35	0.18	0.32	0.3	0.13
Total Stockholder Equity	0.91		0.63	0.35	0.97	0.81	0.7	-0.06	0.57	0.25	0.25	0.16	0.25	0.75	0.38	0.9	-0.36	0.87	0.47	0.24	0.45	-0.24	-0.17	0.22	0.52	0.27
Current Deferred Revenue	0.52	0.63		0.1	0.69	0.36	0.22	-0.26	0.25	0.04	0.12	-0.09	0.12	0.34	0.26	0.48	-0.28	0.46	0.47	0.22	0.48	-0.71	-0.15	0.05	0.31	0.12
Net Debt	0.66	0.35	0.1		0.43	0.58	0.55	0.11	0.87	0.22	-0.31	0.63	-0.31	0.83	0.91	0.65	0.22	0.35	-0.47	0.37	0.08	-0.3	0.65	0.23	-0.11	-0.16
Retained Earnings	0.92	0.97	0.69	0.43		0.82	0.72	-0.06	0.63	0.28	0.13	0.21	0.13	0.79	0.49	0.92	-0.26	0.87	0.41	0.3	0.39	-0.35	-0.08	0.23	0.42	0.26
Accounts Payable	0.92	0.81	0.36	0.58	0.82		0.67	-0.02	0.83	0.43	-0.06	0.43	-0.06	0.87	0.62	0.94	-0.07	0.85	0.01	0.18	0.12	-0.27	0.11	0.17	0.11	0.1
Net Receivables	0.74	0.7	0.22	0.55	0.72	0.67		-0.17	0.6	0.11	-0.02	0.35	-0.02	0.74	0.5	0.81	-0.22	0.79	0.18	0.28	0.19	0.06	0.1	0.16	0.2	0.01
Short Term Investments	-0.01	-0.06	-0.26	0.11	-0.06	-0.02	-0.17		0.06	0.67	-0.11	-0.08	-0.11	0.07	0.14	-0.04	0.2	-0.32	-0.16	0.06	-0.48	-0.02	0.23	0.28	0.01	0.77
Total Liab	0.86	0.57	0.25	0.87	0.63	0.83	0.6	0.06		0.49	-0.27	0.73	-0.27	0.91	0.92	0.84	0.23	0.58	-0.3	0.43	0.05	-0.39	0.56	0.36	-0.04	-0.07
Total Current Assets	0.41	0.25	0.04	0.22	0.28	0.43	0.11	0.67	0.49		-0.33	0.34	-0.33	0.36	0.47	0.36	0.34	0.11	-0.14	0.35	-0.51	-0.34	0.41	0.5	-0.1	0.55
Capital Stock	0.02	0.25	0.12	-0.31	0.13	-0.06	-0.02	-0.11	-0.27	-0.33		-0.35	1.0	-0.14	-0.43	-0.01	-0.79	0.1	0.74	-0.31	0.73	0.44	-0.74	-0.23	0.88	0.19
Short Term Debt	0.47	0.16	-0.09	0.63	0.21	0.43	0.35	-0.08	0.73	0.34	-0.35		-0.35	0.58	0.64	0.44	0.44	0.27	-0.41	0.58	-0.14	-0.08	0.6	0.45	-0.13	-0.38
Common Stock	0.02	0.25	0.12	-0.31	0.13	-0.06	-0.02	-0.11	-0.27	-0.33	1.0	-0.35		-0.14	-0.43	-0.01	-0.79	0.1	0.74	-0.31	0.73	0.44	-0.74	-0.23	0.88	0.19
Intangible Assets	0.93	0.75	0.34	0.83	0.79	0.87	0.74	0.07	0.91	0.36	-0.14	0.58	-0.14		0.81	0.93	0.05	0.69	-0.1	0.43	0.14	-0.31	0.33	0.31	0.12	0.09
Long Term Debt	0.7	0.38	0.26	0.91	0.49	0.62	0.5	0.14	0.92	0.47	-0.43	0.64	-0.43	0.81		0.67	0.37	0.35	-0.4	0.51	-0.03	-0.53	0.74	0.38	-0.19	-0.02
Good Will	0.98	0.9	0.48	0.65	0.92	0.94	0.81	-0.04	0.84	0.36	-0.01	0.44	-0.01	0.93	0.67		-0.15	0.88	0.14	0.31	0.24	-0.28	0.12	0.2	0.25	0.12
Treasury Stock	-0.1	-0.36	-0.28	0.22	-0.26	-0.07	-0.22	0.2	0.23	0.34	-0.79	0.44	-0.79	0.05	0.37	-0.15		-0.28	-0.66	0.38	-0.58	-0.26	0.73	0.38	-0.64	-0.12
Property Plant Equipment	0.84	0.87	0.46	0.35	0.87	0.85	0.79	-0.32	0.58	0.11	0.1	0.27	0.1	0.69	0.35	0.88	-0.28		0.31	0.07	0.34	-0.09	-0.13	0.04	0.28	-0.06
Net Tangible Assets	0.14	0.47	0.47	-0.47	0.41	0.01	0.18	-0.16	-0.3	-0.14	0.74	-0.41	0.74	-0.1	-0.4	0.14	-0.66	0.31		0.01	0.57	0.2	-0.73	0.01	0.81	0.41
Deferred Long Term Liab	0.37	0.24	0.22	0.37	0.3	0.18	0.28	0.06	0.43	0.35	-0.31	0.58	-0.31	0.43	0.51	0.31	0.38	0.07	0.01		-0.05	-0.27	0.5	0.79	0.04	0.06
Long Term Investments	0.3	0.45	0.48	0.08	0.39	0.12	0.19	-0.48	0.05	-0.51	0.73	-0.14	0.73	0.14	-0.03	0.24	-0.58	0.34	0.57	-0.05		0.04	-0.39	-0.11	0.72	-0.18
Short Long Term Debt	-0.35	-0.24	-0.71	-0.3	-0.35	-0.27	0.06	-0.02	-0.39	-0.34	0.44	-0.08	0.44	-0.31	-0.53	-0.28	-0.26	-0.09	0.2	-0.27	0.04		-0.39	-0.17	0.31	-0.05
Long Term Debt Total	0.18	-0.17	-0.15	0.65	-0.08	0.11	0.1	0.23	0.56	0.41	-0.74	0.6	-0.74	0.33	0.74	0.12	0.73	-0.13	-0.73	0.5	-0.39	-0.39		0.47	-0.54	-0.21
Cash And Equivalents	0.32	0.22	0.05	0.23	0.23	0.17	0.16	0.28	0.36	0.5	-0.23	0.45	-0.23	0.31	0.38	0.2	0.38	0.04	0.01	0.79	-0.11	-0.17	0.47		0.06	0.24
Net Invested Capital	0.3	0.52	0.31	-0.11	0.42	0.11	0.2	0.01	-0.04	-0.1	0.88	-0.13	0.88	0.12	-0.19	0.25	-0.64	0.28	0.81	0.04	0.72	0.31	-0.54	0.06		0.33
Net Working Capital	0.13	0.27	0.12	-0.16	0.26	0.1	0.01	0.77	-0.07	0.55	0.19	-0.38	0.19	0.09	-0.02	0.12	-0.12	-0.06	0.41	0.06	-0.18	-0.05	-0.21	0.24	0.33

Click cells to compare fundamentals

About Novartis Financial Statements

Novartis shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Novartis investors may analyze each financial statement separately, they are all interrelated. The changes in Novartis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Novartis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	21.93	17.82
Tangible Book Value Per Share	(3.75)	(3.56)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Novartis Stock Analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC